|
Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18. English, Spanish. PubMed PMID: 22609214.
AÑO: 2012; IF: 3.204
|
22609214
|
Marín F, Roldán V, Lip GY. Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable? Expert Opin Pharmacother. 2012 Jun;13(8):1087-90. doi: 10.1517/14656566.2012.688954. Epub 2012 May 9. PubMed PMID: 22568622.
AÑO: 2012; IF: 2.86
|
|
Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2012 Apr;5(2):312-8. doi: 10.1161/CIRCEP.111.967000. Epub 2012 Feb 7. PubMed PMID: 22319005.
AÑO: 2012; IF: 1.241
|
|
Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. PubMed PMID: 24055744.
AÑO: 2013; IF: 15.343
|
|
Vílchez JA, Roldán V, Manzano-Fernández S, Fernández H, Avilés-Plaza F, Martínez-Hernández P, Vicente V, Valdés M, Marín F, Lip GY. ?-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. Chest. 2013 Nov;144(5):1564-70. doi: 10.1378/chest.13-0922. PubMed PMID: 23975142.
AÑO: 2013; IF: 7.132
|